Similarly, immunofluorescence staining showed that rapamycin blunts the therapeutic effects of ASIV on renal fibrosis in TGF-β1-stimulated HK-2 cells (Figure 7g–j). This evidence concerns the gene TGFB1 and renal fibrosis.